Cite
HARVARD Citation
Dieci, M. et al. (2018). First Prospective Multicenter Italian Study on the Impact of the 21‐Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer. Oncologist. pp. 297-305. [Online].